免疫治疗新 ROR:通过单克隆抗体和 CAR NK 细胞靶向 ROR1 近端结构域治疗乳腺癌
A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cells.
78.6分
★★★★☆
站内排序·非疗效
ALL SOURCES
A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cells.
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma.
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.
NKTR-255, a polymer-conjugated IL-15, synergizes with CAR-T cell therapy to activate endogenous anti-tumor immunity and improve tumor control.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。